Evidence map›Paper›PMID 36410826›Full record

ArticleBMJ open2022

Service-level barriers to and facilitators of access to services for the treatment of alcohol use disorder and problematic alcohol use: protocol for a scoping review.

Dianna Wolfe, Brian Hutton, Kimberly Corace, Nathorn Chaiyakunapruk, Surachat Ngorsuraches, Surapon Nochaiwong, Justin Presseau, Alyssa Grant, Kelly Suschinsky, Becky Skidmore and 9 more

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 9 institutions in 3 countries.

Dianna Wolfe *Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.ORCID 0000-0003-1807-6647
Brian Hutton *Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.ORCID 0000-0001-5662-8647
Kimberly CoraceClinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Nathorn ChaiyakunaprukDepartment of Pharmacotherapy, University of Utah, Salt Lake City, Utah, USA.
Surachat NgorsurachesHarrison College of Pharmacy, Auburn University, Auburn, Alabama, USA.
Surapon NochaiwongDepartment of Pharmaceutical Care, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand.ORCID 0000-0003-1100-7171
Justin PresseauClinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Alyssa GrantClinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Kelly SuschinskySubstance Use and Concurrent Disorders Program, Royal Ottawa Mental Health Centre, Ottawa, Ontario, Canada.
Becky SkidmoreClinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Mary BartramMental Health Commission of Canada, Ottawa, Ontario, Canada.
Karen CohenCanadian Psychological Association, Ottawa, Ontario, Canada.
Gord GarnerCommunity Addictions Peer Support Association, Ottawa, Ontario, Canada.
Lisha DiGioacchinoCommunity Addictions Peer Support Association, Ottawa, Ontario, Canada.
Andrew PumpCommunity Addictions Peer Support Association, Ottawa, Ontario, Canada.
Brianne PetersCommunity Addictions Peer Support Association, Ottawa, Ontario, Canada.
Sarah KonefalResearch, Canadian Centre on Substance Use and Addiction, Ottawa, Ontario, Canada.
Amy PorathCanadian Centre on Substance Use and Addiction, Ottawa, Ontario, Canada.
Kednapa ThavornClinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada kthavorn@ohri.ca.ORCID 0000-0003-4738-8447
University of Ottawa · CAOttawa Hospital · CACanadian Centre on Substance Use and Addiction · CAAuburn University · USCanadian Psychological Association · CAChiang Mai University · THMental Health Commission of Canada · CARoyal Ottawa Mental Health Centre · CAUniversity of Utah · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPrior to the COVID-19 pandemic, substance use health services for treatment of alcohol use disorder and problematic alcohol use (AUD/PAU) were fragmented and challenging to access. The pandemic magnified system weaknesses, often resulting in disruptions of treatment as alcohol use during the pandemic rose. When treatment services were available, utilisation was often low for various reasons. Virtual care was implemented to offset the drop in in-person care, however accessibility was not universal. Identification of the characteristics of treatment services for AUD/PAU that impact accessibility, as perceived by the individuals accessing or providing the services, will provide insights to enable improved access. We will perform a scoping review that will identify characteristics of services for treatment of AUD/PAU that have been identified as barriers to or facilitators of service access from the perspectives of these groups. METHODS AND ANALYSIS: We will follow scoping review methodological guidance from the Joanna Briggs Institute. Using the OVID platform, we will search Ovid MEDLINE including Epub Ahead of Print and In-Process and Other Non-Indexed Citations, Embase Classic+Embase, APA PsychInfo, Cochrane Register of Controlled Trials, the Cochrane Database of Systematic Reviews and CINAHL (Ebsco Platform). Multiple reviewers will screen citations. We will seek studies reporting data collected from individuals with AUD/PAU or providers of treatment for AUD/PAU on service-level factors affecting access to care. We will map barriers to and facilitators of access to AUD/PAU treatment services identified in the relevant studies, stratified by service type and key measures of inequity across service users. ETHICS AND DISSEMINATION: This research will enhance awareness of existing evidence regarding barriers to and facilitators of access to services for the treatment of alcohol use disorder and problematic alcohol use. Findings will be disseminated through publications, conference presentations and a stakeholder meeting. As this is a scoping review of published literature, no ethics approval was required.

Indexed as

AlcoholismCOVID-19Health ServicesHumansPandemicsScoping Reviews as Topicmental health treatment servicesprimary careproblematic alcohol useprotocols & guidelinessubstance misuse

Identifiers

PMID36410826
PMCPMC9680171
OpenAlexW4309534736

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.